Keith Katkin, President & CEO, Director at Avanir Pharmaceuticals, holds 90.00K shares in Syndax Pharmaceuticals (Ticker: SNDX), holds 59.87K shares in Emergent Biosolutions (Ticker: EBS), holds 25.00K shares in Rigel (Ticker: RIGL).
Keith Katkin latest transaction was an Uninformative Buy of ―.
What was Keith Katkin's most profitable transaction?
Keith Katkin’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Keith Katkin's role in Avanir Pharmaceuticals?
Keith Katkin's role in Avanir Pharmaceuticals is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.